Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(2.47)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
INKT MiNK Therapeutics | Upgrades: Buy | 35 35 | 14.9 | 134.9% | 14 | Aug 15, 2025 | |
VTVT vTv Therapeutics | Reiterates: Buy | 36 36 | 15.2 | 136.84% | 2 | Aug 13, 2025 | |
FEMY Femasys | Maintains: Buy | 12 8 | 0.56 | 1328.57% | 25 | Aug 11, 2025 | |
CNTX Context Therapeutics | Maintains: Buy | 5 4 | 0.89 | 349.44% | 12 | Aug 7, 2025 | |
SABS SAB Biotherapeutics | Maintains: Buy | 10 9 | 2.18 | 312.84% | 2 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 6 27 | 11.31 | 138.73% | 2 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 40 20 | 2.93 | 582.59% | 10 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 36 36 | 5.11 | 604.5% | 9 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 115 115 | 71.28 | 61.34% | 13 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 12 | 2.88 | 316.67% | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 25 | 4.52 | 453.1% | 18 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 22 38 | 20.22 | 87.93% | 10 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 30 30 | 5.76 | 420.83% | 20 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 11 11 | 3.58 | 207.26% | 11 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 32 32 | 0.7 | 4471.43% | 14 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 560 280 | 10.26 | 2629.04% | 17 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 8 | 1.83 | 337.16% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 1.74 | 589.66% | 13 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 30 30 | 3.78 | 693.65% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 19 19 | 1.36 | 1297.06% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 18 18 | 2.37 | 659.49% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 183 183 | 6.52 | 2700.77% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 7 7 | 0.78 | 797.44% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 24 | 10.53 | 127.92% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 58 58 | 38.8 | 49.48% | 1 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 18 18 | 1.13 | 1492.92% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 15 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 38 38 | 12.43 | 205.71% | 18 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 8 6 | 2.27 | 164.32% | 13 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 33 33 | 2.31 | 1328.57% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 1 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 13 10 | 10.25 | -2.44% | 6 | Dec 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 48 | 47.55 | 0.95% | 8 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Dec 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 16 | n/a | n/a | 1 | Apr 13, 2022 |